ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,159 | -48.6% | 13,714 | -49.0% | 0.11% | -33.7% |
| Q1 2023 | $132,723 | -32.7% | 26,867 | -14.3% | 0.16% | -28.5% |
| Q4 2022 | $197,122 | -21.2% | 31,339 | +35.4% | 0.23% | -20.3% |
| Q3 2022 | $250,000 | -41.9% | 23,137 | -38.6% | 0.29% | -3.4% |
| Q2 2022 | $430,000 | +205.0% | 37,713 | +144.1% | 0.30% | +179.2% |
| Q1 2022 | $141,000 | -7.8% | 15,449 | +51.1% | 0.11% | -35.0% |
| Q4 2021 | $153,000 | – | 10,223 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |